MELODY ODELL: Open Payments
NPI 1235724907 · BULLARD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 81 payments from 10 companies in 2025. Trend: 2023 $579 · 2024 $1,433 · 2025 $1,237
Food & beverage: $1,237
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $274 |
| PFIZER INC. | 10 | $202 |
| Novo Nordisk Inc | 9 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $160 |
| GlaxoSmithKline, LLC. | 9 | $146 |
| AstraZeneca Pharmaceuticals LP | 7 | $114 |
| Lilly USA, LLC | 7 | $97 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| Abbott Laboratories | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
Products named: Kerendia, ELIQUIS, JARDIANCE, TRELEGY ELLIPTA, Ozempic, AIRSUPRA, MOUNJARO, Wegovy.
Industry payments across TX — which companies pay providers there.
